Cargando…

Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients

Detalles Bibliográficos
Autores principales:	Amoozgar, Zohreh, Jaymand, Mehdi, Jahanban-Esfahlan, Rana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406513/ https://www.ncbi.nlm.nih.gov/pubmed/37554172 http://dx.doi.org/10.3389/fonc.2023.1226974

Ejemplares similares

Tumor microenvironment penetrating chitosan nanoparticles for elimination of cancer relapse and minimal residual disease
por: Mahmudi, Hossein, et al.
Publicado: (2022)

Horizontal Gene Transfer: From Evolutionary Flexibility to Disease Progression
por: Emamalipour, Melissa, et al.
Publicado: (2020)

Editorial: The Upcoming Complications of COVID-19 on Recovered Patients: Molecular Mechanisms and Therapeutic Opportunities
por: Jahanban-Esfahlan, Rana, et al.
Publicado: (2022)

Editorial: The upcoming complications of COVID-19 on recovered patients: molecular mechanisms and therapeutic opportunities, volume II
por: Seradj, Seyed Hassan, et al.
Publicado: (2023)

Static DNA Nanostructures For Cancer Theranostics: Recent Progress In Design And Applications
por: Jahanban-Esfahlan, Rana, et al.
Publicado: (2019)

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
por: Yao, Qiumei, et al.
Publicado: (2019)

Editorial: Circulating tumor DNA in cancer: a role as a response and monitoring “next-generation” biomarker in cancer therapy
por: Latifi-Navid, Saeid, et al.
Publicado: (2023)

Tumor microenvironment complexity and therapeutic implications at a glance
por: Baghban, Roghayyeh, et al.
Publicado: (2020)

Roles of miRNAs in Colorectal Cancer: Therapeutic Implications and Clinical Opportunities
por: Mehrgou, Amir, et al.
Publicado: (2021)

“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow
por: Pacelli, Paola, et al.
Publicado: (2022)

Recent advances in the use of walnut (Juglans regia L.) shell as a valuable plant-based bio-sorbent for the removal of hazardous materials
por: Jahanban-Esfahlan, Ali, et al.
Publicado: (2020)

Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy
por: Ferla, Valeria, et al.
Publicado: (2022)

Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer
por: Jahanban-Esfahlan, Rana, et al.
Publicado: (2019)

Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCR
por: Yao, Qiumei, et al.
Publicado: (2021)

Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies
por: Sánchez, Ricardo, et al.
Publicado: (2019)

Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
por: Maiolino, Angelo, et al.
Publicado: (2023)

Editorial: Minimally-invasive treatment for genitourinary cancers: what comes next?
por: Chierigo, Francesco, et al.
Publicado: (2023)

Editorial: Next generation staging in head and neck cancers
por: Iyer, N. Gopalakrishna, et al.
Publicado: (2022)

Clinical implication of minimal residual disease assessment by next-generation sequencing-based immunoglobulin clonality assay in pediatric B-acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2022)

The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients
por: Esfahlan, R. Jahanban, et al.
Publicado: (2011)

Editorial: Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology
por: Buzdin, Anton, et al.
Publicado: (2021)

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms
por: Aguirre-Ruiz, Paula, et al.
Publicado: (2020)

Walnut (Juglans regia L.) shell pyroligneous acid: chemical constituents and functional applications
por: Jahanban-Esfahlan, Ali, et al.
Publicado: (2018)

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
por: Peng, Yan, et al.
Publicado: (2021)

Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer
por: Jiang, Jiahong, et al.
Publicado: (2020)

Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma
por: Liu, Tao, et al.
Publicado: (2021)

Melanoma Immunotherapy: Next-Generation Biomarkers
por: Hogan, Sabrina A., et al.
Publicado: (2018)

Detection of minimal residual disease by next generation sequencing in AL amyloidosis
por: Sarosiek, Shayna, et al.
Publicado: (2021)

Dynamics of Minimal Residual Disease in Neuroblastoma Patients
por: Uemura, Suguru, et al.
Publicado: (2019)

Antioxidants in different parts of oleaster as a function of genotype
por: Faramarz, Samaneh, et al.
Publicado: (2015)

Preparation and Antiproliferative Activity Evaluation of Juglone-Loaded BSA Nanoparticles
por: Jahanban-Esfahlan, Ali, et al.
Publicado: (2022)

Recent advances in targeted drug delivery systems for resistant colorectal cancer
por: Sharifi-Azad, Masoumeh, et al.
Publicado: (2022)

Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2022)

Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
por: Charalampous, Charalampos, et al.
Publicado: (2022)

Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2015)

Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023)

Liquid biopsies and minimal residual disease in lymphoid malignancies
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma
por: Wu, Xiao-Bo, et al.
Publicado: (2022)

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
por: Medina, Alejandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u9mn8qaom0bb9aol5ri4satigh